- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Interferon Beta-1A
Total 7576 results
-
BiogenCompletedMultiple SclerosisUnited States, Spain, Hungary, Serbia, Canada, France, Poland, Russian Federation, Netherlands, Czech Republic, Italy, United Kingdom
-
Hoffmann-La RocheCompletedRelapsing Multiple SclerosisUnited States, Spain, Czechia, Belgium, Italy, Canada, United Kingdom, Germany, Ireland, Turkey, Poland, Russian Federation, Ukraine, Croatia, Argentina, France, Belarus, Brazil, Mexico, Bosnia and Herzegovina, Bulgaria, Slovakia, S... and more
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
-
Nancy Hammond, MDKansas City Area Life Sciences Institute, Inc.CompletedMultiple Sclerosis | Low Bone DensityUnited States
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden and other collaboratorsCompletedMultiple Sclerosis, Relapsing RemittingGreece
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
Faron Pharmaceuticals LtdTerminatedPreventive Medicine | Multi Organ FailureLithuania, Estonia, Finland
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
Louisiana State University Health Sciences Center...BiogenCompletedMultiple SclerosisUnited States
-
EMD SeronoTerminatedCrohn's DiseaseGermany, Italy, Sweden, Switzerland, United Kingdom
-
BiogenTerminatedMultiple SclerosisUnited States
-
BiogenTerminatedRelapsing Remitting Multiple SclerosisAustralia
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-Remitting
-
BiogenCompletedMultiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, FranceCompletedMultiple Sclerosis, Relapsing, Remitting
-
National Institute of Neurological Disorders and...Completed
-
Teva Branded Pharmaceutical Products R&D, Inc.Withdrawn
-
BiogenActive, not recruitingRelapsing-Remitting Multiple SclerosisItaly, Belgium, United States, Hungary, Sweden, United Kingdom, Israel, France, Czechia, Poland, Serbia, Denmark, Spain, Turkey, Bulgaria, Germany, Canada, Kuwait
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
BiogenCompletedMultiple SclerosisUnited States, Australia, Austria, Canada
-
BiogenCompleted
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
BiogenRecruitingMultiple SclerosisUnited States, Germany
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
BiogenCompleted
-
BiocadCompletedHealthyRussian Federation
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.P.A., ItalyCompleted
-
CelgeneCompletedMultiple SclerosisUnited States, Spain, Czechia, Russian Federation, Portugal, Serbia, United Kingdom, New Zealand, Belarus, Bulgaria, Poland, Romania, Estonia, Germany, Sweden, Ukraine, Hungary, Croatia, Georgia, Bosnia and Herzegovina, Latvia, Li... and more
-
BiogenCompletedMultiple SclerosisBelgium
-
Qassim UniversityUnknown
-
Aaron BosterPfizer; EMD SeronoCompleted
-
Saint Francis CareBiogenCompleted
-
Shahid Beheshti University of Medical SciencesUnknown
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.P.A., ItalyCompleted
-
Rennes University HospitalCompleted
-
CelgeneCompletedRelapsing Multiple SclerosisSpain, United States, United Kingdom, Croatia, Serbia, Belarus, Hungary, Bulgaria, Poland, Italy, Ukraine, Greece, Belgium, Georgia, Bosnia and Herzegovina, Moldova, Republic of, Romania, Russian Federation, Slovakia, South Africa and more
-
University of California, San FranciscoOregon Health and Science University; National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyMerck Romania SRL, an affiliate of Merck KGaA, Darmstadt, GermanyCompletedClinically Isolated Syndrome | Relapsing Multiple SclerosisGermany
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, France, United States, Germany, Canada, United Kingdom, Russian Federation, Argentina, Brazil, Croatia, Poland, Serbia, Sweden, Ukraine, Czech Republic, Mexico
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
BiogenCompleted
-
Fred LublinNational Institute of Neurological Disorders and Stroke (NINDS)CompletedRelapsing Remitting Multiple SclerosisUnited States, Canada